Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:

 

 

 

Three months ended March 31,

 

 

 

2026

 

 

2025

 

Research and development*

 

$

1,790,700

 

 

$

453,186

 

Selling, general and administrative

 

 

3,769,066

 

 

 

1,589,010

 

Total stock-based compensation expense

 

$

5,559,766

 

 

$

2,042,196

 

 

*Includes $0.4 million and $0.3 million for the three months ended March 31, 2026 and 2025, respectively, related to the restricted stock awards issued in connection with the acquisition of CorHepta.